Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Tech Stocks Fall Late Afternoon

Sector Update: Tech Stocks Fall Late Afternoon

MT newswireMT newswire2026/09/28 19:57
03:57 PM EDT, 09/28/2026 (MT Newswires) -- Tech stocks were lower late Monday afternoon, with the State Street Technology Select Sector SPDR ETF (XLK) down 1% and the State Street SPDR S&P Semiconductor ETF (XSD) falling 2.5%. The Philadelphia Semiconductor index shed 1.7%. In corporate news, MongoDB (MDB) said Monday that Chirantan Desai has stepped down as president and CEO of the firm to pursue a senior role at Meta Platforms (META). The company appointed Dev Ittycheria as interim president and CEO, effective immediately. The shares fell past 17.5%. Nvidia (NVDA) shares climbed 1.6% after the tech giant said it expanded its share buyback program by $150 billion. It also launched a software platform to help AI developers test and deploy their agents with more governance controls. Roblox (RBLX) shares fell past 9% after Jefferies downgraded the stock to underperform from hold, with a $38 price target. Snowflake (SNOW) said Monday it plans to offer $1.3 billion of its 0.0% convertible senior notes due 2029 and $2.2 billion of its 0.0% convertible senior notes due 2031. Its shares fell 2.3%.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%

Researchers combined Amgen's Imdelltra with AstraZeneca's Imfinzi and found that for patients with aggressive lung cancer whose tumors had already spread, this combination extended survival by about eight months compared to Imfinzi monotherapy. Small cell lung cancer is one of the cancer types with the worst prognosis.

智通财经•2026/10/25 02:56
Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%